Preview

Medical Immunology (Russia)

Advanced search

CHARACTERISTICS OF CYTOKINE PROFILE LEVEL (TNFα, IL-6, IL-10) AND THEIR SOLUBLE RECEPTORS (SRр55 TNFα, SRр75 TNFα, SR IL-6) IN THE PATIENTS WITH HIV, HIV-ASSOCIATED TUBERCULOSIS AND PULMONARY TUBERCULOSIS

https://doi.org/10.15789/1563-0625-2008-6-519-526

Abstract

Abstract. Three groups of patients were investigated as follows: 1st group, HIV-infected patients, 2nd group, patients with HIV-associated tuberculosis, the 3rd group, persons with pulmonary tuberculosis. The amounts of cytokines (TNFα, IL-6, IL-10) and their soluble receptors (SRp55 TNFα, SRp75 TNFα, SR IL-6) were evaluated in blood serum by solid-phase immuno-enzyme technique. The patients did not receive antiviral therapy before, or during the investigations. Some features are revealed reflecting a direction and significance of changes in immune reactivity of the patients. In the patients with tuberculosis, IL-10 and IL-6 levels were increased, along with pronounced rise of srIL-6, relatively low index of SRp75 TNFα and deficiency of SRp55 TNFα, associated with moderate increase in TNFα. In the patients with HIV and HIV-associated tuberculosis, the direction of alterations were found to be similar, except of IL-10, i.e., a hyper-production of TNFα and its soluble type I and II receptors, increased IL-6 level in combination with lack of its soluble receptor. Correlation analysis showed a strict dependence between TNFα and viral load in the patients with IVB and V stage of HIV, and HIV-associated tuberculosis that argues for significance of TNFα in pathogenesis of HIV-infection and its progression. We have found differential trends in dynamics of cytokines under study and their soluble receptors in the course of HIV-infection progression in the groups I and II of patients, that allowing us of elaborating additional diagnostic criteria of HIV-associated tuberculosis. (Med. Immunol., vol. 10, N 6, pp 519-526).

About the Authors

E. V. Markelova
ГОУ ВПО Владивостокский государственный медицинский университет, г. Владивосток
Russian Federation


S. A. Sotnichenko
ГУ Краевой клинический центр по профилактике СПИД и инфекционных заболеваний, г. Владивосток
Russian Federation


L. F. Sklyar
ГОУ ВПО Владивостокский государственный медицинский университет, г. Владивосток
Russian Federation


A. E. Safronov
ГОУ ВПО Владивостокский государственный медицинский университет, г. Владивосток
Russian Federation


References

1. Бородулин Б.Е., Бородулина Е.А., Куликова И.И., Курбатова Е.В. Марченко Г.Р., Калинкин А.В. Туберкулез у ВИЧ-инфицированных в крупном промышленном центре // Пульмонология. – 2007. – № 2. – С. 56-58.

2. Ермак Т.Н., Кравченко А.В., Груздев Б.М. Вторичные заболевания у больных ВИЧ - инфекцией – 15-летнее наблюдение // Тер. архив. – аТ2004. – № 4. – С. 18-20.

3. Козлов В.К., Егорова В.Н. Патогенез ВИЧ - инфекции. Возможности иммунотерапии цитокинами. – СПб., 2001. – 32 с.

4. Назаров П.Г. Реактанты острой фазы. – СПб.: Наука, 2001. – 423 с.

5. Покровский В.В., Ладная Н.Н., Соколова Е.В., Юрин О.Г. Эпидемиология ВИЧ - инфекции в Российских регионах в 2004 г. // Проблемы туберкулеза и болезней легких. – 2005. – № 10. – С. 3-13.

6. Рахманова А.Г. ВИЧ-инфекция. Клиника и лечение. – СПб.: ССЗ, 2000. – 370 с.

7. Соколова Ю.В., Сизякина Л.П. Особенности секреции цитокинов и их рецепции в динамике ВИЧ-инфекции // Иммунология. – 2007. – № 7. – С. 324-327.

8. Смольникова М.В., Прокофьев В.Ф., Сизякина Л.П. Аллельные варианты генов IL-4, IL-10 и TNFα при ВИЧ-инфекции // Цитокины и воспаление. – 2002. – Т. 1, № 1. – С. 29-32.

9. Хонина Л.Б., Никонов С.Д., Шпилевский С.В. Особенности иммунитета у больных различными формами туберкулеза легких // Проблемы туберкулеза. – 2000. – № 1. – С. 30-32.

10. Aliyu M.H., Salihu H.M. Tuberculosis and HIV coinfection – a symbiotic relationship // Eur. J. Med. – 2004. – Vol. 115. – P. 685-697.

11. Aziz N., Nishanian P., Taylor J.M., Hallahan G., Chang N.K. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. // J. Infect. Dis. – 1999. – Vol. 179, N 4. – Р. 843-848.

12. Fahry J.L., Taylor J.M., Manna B. Prognostic significance of plasma markers og immune activation, HIV viral load and CD4 T-cell measurements // AIDS. – 1998. – Vol. 12, N 13. – Р. 1581-1590.

13. Fakoya A., Matear P.M., Filley E. HIV infection alters the production of both type 1 and 2 cytokines but does not induce a polarized type 1 or 2 state // AIDS. – 1997. – Vol. 11, N 12. – Р. 1445-1452.

14. Ferbas J. Perspectives on the role of CD8+cell suppressor factors and cytotoxic T-lymphocytes during HIV infection // AIDS Res. Hum. Retrovir. – 1998. – Vol. 14, suppl. 2. – P. 153-160.

15. Klein S.A., Dobmeyer J.M. Demonstration of the Thl to Th2 cytokine shift during the course of HIV-I infection using cytoplasmic cytokine detection on single cell level by flow cytometry // AIDS. – 1997. – Vol. 11, N 9. – Р. 1111-1118.

16. Lafeuillade A., Poizot-Martin I., Quilichini R. Increased IL-6 production is associated with disease progression on HIV infection // AIDS. – 1991. – Vol. 5, N 9. – Р. 1139-1140.

17. Saile Mih B., Ramodori F.J. Apoptosis // Mediana Viral Join. – 2003. – Vol. 69, N 1. – P. 50-58.

18. Shearer G.M, Clerici M. Cytokine profiles in HIV type 1 desease and protection // AIDS Res. Human Retrovir. – 1998. – Vol. 14, suppl. 2. – Р. 149-152.


Review

For citations:


Markelova E.V., Sotnichenko S.A., Sklyar L.F., Safronov A.E. CHARACTERISTICS OF CYTOKINE PROFILE LEVEL (TNFα, IL-6, IL-10) AND THEIR SOLUBLE RECEPTORS (SRр55 TNFα, SRр75 TNFα, SR IL-6) IN THE PATIENTS WITH HIV, HIV-ASSOCIATED TUBERCULOSIS AND PULMONARY TUBERCULOSIS. Medical Immunology (Russia). 2008;10(6):519-526. (In Russ.) https://doi.org/10.15789/1563-0625-2008-6-519-526

Views: 976


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)